Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 39 | 2025 | 1732 | 8.010 |
Why?
|
Prostate | 19 | 2025 | 402 | 4.140 |
Why?
|
Magnetic Resonance Imaging | 32 | 2025 | 3465 | 3.860 |
Why?
|
Diffusion Magnetic Resonance Imaging | 20 | 2024 | 300 | 3.280 |
Why?
|
Prostatic Hyperplasia | 2 | 2020 | 90 | 1.240 |
Why?
|
Image-Guided Biopsy | 3 | 2025 | 78 | 1.180 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2024 | 1254 | 1.120 |
Why?
|
Prostatectomy | 8 | 2023 | 474 | 1.100 |
Why?
|
Contrast Media | 9 | 2023 | 1084 | 0.960 |
Why?
|
Male | 40 | 2025 | 42464 | 0.930 |
Why?
|
Mobile Applications | 1 | 2023 | 71 | 0.780 |
Why?
|
Radiology | 1 | 2023 | 201 | 0.720 |
Why?
|
Neoplasm Grading | 6 | 2023 | 374 | 0.670 |
Why?
|
Humans | 40 | 2025 | 89567 | 0.610 |
Why?
|
Artificial Intelligence | 1 | 2020 | 327 | 0.580 |
Why?
|
Prospective Studies | 7 | 2025 | 4309 | 0.550 |
Why?
|
Retrospective Studies | 12 | 2024 | 9112 | 0.540 |
Why?
|
Middle Aged | 18 | 2025 | 25996 | 0.490 |
Why?
|
Reproducibility of Results | 9 | 2024 | 2763 | 0.450 |
Why?
|
Laser Therapy | 3 | 2020 | 148 | 0.440 |
Why?
|
Signal-To-Noise Ratio | 3 | 2024 | 103 | 0.430 |
Why?
|
Aged | 12 | 2025 | 19144 | 0.410 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 1605 | 0.380 |
Why?
|
Feasibility Studies | 4 | 2019 | 781 | 0.320 |
Why?
|
Image Enhancement | 4 | 2021 | 565 | 0.300 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2024 | 688 | 0.300 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 2015 | 0.260 |
Why?
|
Water | 2 | 2023 | 284 | 0.210 |
Why?
|
Adult | 6 | 2019 | 26684 | 0.210 |
Why?
|
Time | 1 | 2022 | 76 | 0.200 |
Why?
|
Meglumine | 2 | 2021 | 38 | 0.200 |
Why?
|
Pathologists | 1 | 2021 | 27 | 0.190 |
Why?
|
Phantoms, Imaging | 1 | 2024 | 453 | 0.190 |
Why?
|
Organometallic Compounds | 2 | 2021 | 136 | 0.180 |
Why?
|
Androgen Antagonists | 1 | 2021 | 138 | 0.180 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 73 | 0.170 |
Why?
|
Algorithms | 2 | 2024 | 1896 | 0.160 |
Why?
|
ROC Curve | 2 | 2018 | 777 | 0.160 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2018 | 35 | 0.150 |
Why?
|
Gadolinium | 1 | 2018 | 103 | 0.150 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 98 | 0.150 |
Why?
|
Multimodal Imaging | 1 | 2018 | 111 | 0.140 |
Why?
|
Biopsy | 1 | 2019 | 1183 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 599 | 0.120 |
Why?
|
Epithelium | 1 | 2015 | 323 | 0.120 |
Why?
|
Artifacts | 1 | 2015 | 246 | 0.110 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 1727 | 0.110 |
Why?
|
Motion | 2 | 2024 | 97 | 0.110 |
Why?
|
Porosity | 1 | 2011 | 61 | 0.100 |
Why?
|
Materials Testing | 1 | 2011 | 93 | 0.100 |
Why?
|
Risk Assessment | 1 | 2019 | 2304 | 0.100 |
Why?
|
Models, Chemical | 1 | 2011 | 179 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 315 | 0.090 |
Why?
|
Models, Molecular | 1 | 2011 | 1313 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2024 | 185 | 0.050 |
Why?
|
Computer Simulation | 2 | 2021 | 1101 | 0.050 |
Why?
|
Radiologists | 1 | 2022 | 48 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2023 | 375 | 0.050 |
Why?
|
Pilot Projects | 1 | 2021 | 870 | 0.040 |
Why?
|
Tumor Burden | 1 | 2018 | 305 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 180 | 0.040 |
Why?
|
Anisotropy | 1 | 2015 | 63 | 0.030 |
Why?
|
Diffusion | 1 | 2015 | 93 | 0.030 |
Why?
|
In Vitro Techniques | 1 | 2015 | 996 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2024 | 6766 | 0.030 |
Why?
|
Brain | 1 | 2023 | 2294 | 0.030 |
Why?
|
Particle Size | 1 | 2011 | 125 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 8209 | 0.020 |
Why?
|